practical alternatives for maintaining gas exchange in the presence of severe lung disease.
Two new approaches to gas exchange have recently been described which have allowed further exploration of these questions. One approach has been to accept the gross gas exchange inefficiencies of the damaged lung and provide instead for normal oxygen and/or carbon dioxide transport by extracorporeal membrane exchange. The other approach has been to enhance pulmonary gas exchange using new methods of artificial ventilation.
Extracorporeal membrane oxygenation
Early results using extracorporeal membrane oxygenation (ECMO) in both experimental animals 8 and man 9 ,tO were encouraging. However, a multicentre, prospective, randomised study subsequently demonstrated no benefit in terms of survival in patients with severe respiratory failure. 11 The latter investigators concluded, rather pessimistically, that it was progressive pulmonary disease (vascular obliteration and fibrosis) which led to the high mortality in patients with adult respiratory distress syndrome (ARDS) and that it was not possible to reduce this simply by providing a normal blood gas composition by alternative means. Their report, however, was open to a number of important criticisms. For instance, they required patients to have very severe lung disease and to have been treated unsuccessfully with conventional intermittent positive pressure ventilation (IPPV) plus PEEP (>5cm H20), for relatively long periods prior to entry into the study. Thus, if ventilator-induced pulmonary damage was important in progression of disease and prognosis in such patients, it seems quite possible that their study design may have masked any beneficial effect of ECMO treatment. Furthermore, compared with control patients, patients randomised to ECMO were sUbjected to a longer period of mechanical ventilation before entry to the trial, and were continued on mechanical ventilation (albeit at lower rates and tidal volumes) during ECMO.
More recently other investigators have reported the successful treatment of three patients with severe respiratory failure using an extracorporeal membrane circuit but a somewhat different strategy.12 In this study the lung was 'rested' (only three breaths per minute); C02 excretion was provided by a venovenous extracorporeal membrane exchange circuit; and normal Pa02 was maintained by continuous 02 insufflation via a tracheal cannula. The authors stressed the importance of weaning patients from their support system only when the mechanical properties of the lung had recovered sufficiently to permit conventional IPPV at normal pressures and tidal volumes. A similar technique was shown by Pesenti and colleagues 7 to prevent hyaline membrane disease in premature lambs. Together, these results suggest that the future for extracorporeal gas exchange may not be as gloomy as was initially thought, although definitive answers on the clinical efficacy of this treatment must await further controlled studies.
Regardless of the final outcome of such trials there will remain significant technical difficulties associated with prolonged extracorporeal membrane exchange (e.g. longterm anticoagulation, destruction of formed blood elements). It would clearly be preferable to find an effective, less invasive technique.
High-frequency ventilation
One alternative method of ventilatory support which has attracted a great deal of interest is ventilation using supraphysiologic breathing frequencies. Three different types of Anaesthesia and Intensive Care, Vol. 13 high-frequency, low-tidal volume ventilation have now been used. They are: high-frequency positive pressure ventilation (HFPPV, 1-2 cycles per second); high-frequency jet ventilation (HF JV, up to 7 cycles per second); and high-frequency oscillatory ventilation (HFOV, 5-40 cycles per second). The interested reader is referred to several recent articles in which detailed accounts are given of the historical development of these devices and their modes of operation. [13] [14] [15] [16] High-frequency positive pressure ventilation
The first technique (HFPPV) was developed in the late 1960s by a group of researchers 17 who were concerned to eliminate respirationsynchronous blood pressure variations. These had been distorting measurements they were making on the control of blood pressure by the carotid sinus baroreceptor. These workers were quick to appreciate the potential clinical application of this device. They subsequently modified their ventilator to incorporate a pneumatic valve suitable for supporting ventilation during anaesthesia, laryngoscopy and bronchoscopy. 18 The ventilator was found to be particularly useful during thoracic surgery since it minimised lung movement. These early applications of HFPPV were confined to patients with normal lungs. There are few data on its usefulness in subjects with lung disease.
High-frequency jet ventilation
High-frequency jet ventilation was first described by Klain and Smith in 1977. 19 Subsequent studies have shown that it may have a particular place in the management of patients with massive airleaks, in whom alveolar ventilation cannot be adequately maintained by a conventional ventilator. 20, 21 However, as with HFPPV, there have been relatively few controlled, systemic studies either in patients or experimental animals with severe lung disease, and its role under these circumstances remains uncertain.
High-frequency oscillatory ventilation
The most recent development in this field, and the most exciting from the physiologist's point of view, has been the introduction of HFOV. Most of the subsequent discussion will focus on this particular type of high-frequency ventilation.
In 1980 Bohn and associates 22 reported that normal pulmonary gas exchange could be maintained in experimental animals using ventilatory frequencies of 15 cycles per second. Of great physiologic interest was that this was accomplished with tidal volumes that were substantially less than the anatomical deadspace. It was clear from previous work that tidal volumes with HFPPV and HFJV had approached that of the deadspace, but this was the first unequivocal demonstration that normal ventilatory requirements could be met using tidal volumes less than the volume of the conducting airways. It is not surprising therefore that a great deal of the subsequent research in this area has focused on possible mechanisms of gas exchange in HFOV, the result being that several new and exciting concepts of gas transport have been uncovered. 23 -28 In addition to these physiologic considerations, however, it was predicted that HFOV might be of considerable practical benefit in the treatment of patients with severe lung disease.
At normal, physiologic breathing frequencies the distribution of ventilation within the lung is largely determined by regional lung compliance. 29 In many forms of lung disease compliance is markedly uneven resulting in severe ventilation inhomogeneity. To attempt to reverse this disturbance by using conventional positive pressure ventilators, which simply duplicate physiologic respiratory frequency and tidal volume, seems illogical. High-frequency, low-tidal volume ventilation appeared to offer an effective alternative. Theory predicted that gas transport was unlikely to be substantially influenced by regional lung compliance 28 and early experiments using radioactive tracer gas confirmed that, at least in the normal lung, ventilation was more evenly distributed. 30 It seemed also that airway pressure swings from low-volume oscillations would taper markedly toward the lung periphery, possibly reducing the risk of barotrauma.
A number of different groups have now reported results of treatment with HFOV. The disease models studied include pulmonary oedema induced by oleic acid infusion,31-33 and repeated lung saline lavage; 32 a primate model of neonatal respiratory distress syndrome; 34 diffuse airway constriction by methacholine inhalation 35 or histamine infusion; 36 and airway rupture. 37 Limited data have also been obtained in patients with a variety of lung diseases. [38] [39] [40] Initial results using HFOV in diffuse lung injury were somewhat disappointing. One group that studied oleic acid pulmonary oedema found that it was possible to obtain Pa02 and PaC02 levels with HFOV that were similar to those obtained during conventional IPPV,31 but mean' airway pressure during HFOV needed to be the same as that used with conventional ventilation. Another group studying a model of hyaline membrane disease of the newborn 34 found that progressive hypoxaemia occurred over time on HFOV. Frequent sighs prevented this but also led to a high incidence of airleaks. 41
It seemed, therefore, that while equivalent gas exchange might be possible with HFOV there was no obvious short-term advantage over usual forms of mechanical ventilation. Furthermore, the rate of extravascular fluid accumulation in oleic acid-induced oedema did not appear to be reduced by HFOV, 42 suggesting that there was no particular advantage in terms of disease progression either.
More recently, Kolton and associates 32 reinvestigated the use of HFOV in the treatment of oleic acid lung injury and extended their observations to a model of hyaline membrane disease induced by repeated alveolar lavage. Their results indicate that HFOV, if used in a particular way, is not only superior in terms of gas exchange but might also prevent ventilator-induced lung injury. These workers looked more critically at the interaction of airway pressure, lung volume and gas exchange during HFOV and conventional IPPV. Before instituting mechanical ventilation they ensured that as many atelectatic lung units as possible were recruited with a sustained (10-15 second) inflation at 30cm H20 transpulmonary pressure. The lung was then allowed to deflate to a resting mean airway pressure 5-lOcm H20 above the critical opening pressure (i.e. the pressure corresponding to the inflection point on the inspiratory pressure-volume curve at which lung units begin to suddenly open). With this technique, HFOV sustained excellent oxygenation and CO 2 elimination whereas Anaeslhesia and Intensive Care, Vol. 13 . No. 2, May, /985 application of conventional IPPV at the same mean airway pressure resulted in progressive lung collapse and hypoxaemia. It seemed that the relatively wide pressure and volume excursions during conventional IPPV allowed progressive derecruitment of lung units, but with HFOV the lung remained essentially in a position of static inflation with all, or most, gas exchange units functional.
In another series of experiments the same group compared the long-term effects of HFOV and conventional IPPV on gas exchange and lung morphology in the surfactant-depleted lung. 6 Using the same pre-inflatron strategy they were able to maintain excellent oxygenation without sighs on HFOV. Four of five HFOV -treated animals survived 20 hours. In contrast, all five animals treated with conventional IPPV became progressively hypoxaemic and died. The corresponding morphologic findings were perhaps of even greater importance. All animals that were supported by conventional IPPV were shown post mortem to have developed hyaline membranes in small conducting airways, whereas these were not present in HFOVtreated animals.
Confirmation of these results is, of course, required in other species and experimental models of lung injury before one can begin to extrapolate to human disease. Nevertheless, they represent some of the most important data thus far obtained, relating to possible clinical applications of high-frequency ventilation. On the one hand the study has provided definitive evidence supporting the concept that conventional IPPV may aggravate lung injury in the adult lung, while on the other it suggests that this can be prevented by ventilation at supraphysiologic frequencies.
The eventual role of HFOV in clinical practice is likely to depend on its effects on other non-gas exchange in lung functions as well (e.g. mucociliary transport, fluid filtration, vascular tone). Experimental work to investigate these aspects is generally at an early stage but a number of subtle physiologic alterations consequent upon HFOV have already been identified. It has been shown, for instance, that HFOV retards mucociliary transport more than conventional IPPV when applied via the trachea 43 but not if administered by chest wall vibration. 44 . 45 In addition, preliminary studies in an isolated perfused lung preparation indicate that the hypoxic vasoconstrictor response may be attenuated by HFOV. 46 High-frequency oscillatory ventilation also inhibits spontaneous breathing by airway stretch receptor stimulation and a vagal reflex. 4749 This response may be advantageous in patients who resist conventional IPPV. Other important findings to date are that lung morphology (both at the light and ultrastructural levels) was normal after 4 to 5 hours of HFOV 50 . 51 and HFOV appeared not to have any deleterious effects on haemodynamics 22 . 27 or the distribution of pulmonary27 or systemic 52 blood flow. Alveolar surfactant pool size was not affected by HFOV,50 although surfactant turnover may be enhanced. 53 The field of high-frequency ventilation continues to undergo rapid evolution but for the present there remains considerable uncertainty about which is the most appropriate frequency to use (e.g. 2-7 Hz in HFJV or >5 Hz as in oscillatory ventilation) and which mode of ventilation to employ (e.g. jet, oscillatory motion to the airway, vibration of chest wall, or oscillations superimposed on conventional IPPV). Human studies have, to now, necessarily been limited but trials incorporating the sorts of strategies outlined by Kolton and colleagues 24 are in progress and the results eagerly awaited. The question of whether or not high-frequency ventilation will reduce the incidence of airleaks in the presence of severe, diffuse lung disease has yet to be systematically studied.
Finally, while a great deal of interest has been aroused by the possibility of ventilation at supraphysiologic frequencies, a recent report 54 indicates that it is also possible to provide normal O 2 and C02 exchange by a constant flow of fresh gas via a divided catheter positioned at the level of the tracheal carina. In this study54 animals remained totally apnoeic and there was no extracorporeal membrane exchange. The success of this ventilatory method is yet to be confirmed by other workers, and the need for tracheal positioning of cannulae is an obvious disadvantage. Nevertheless, it is perhaps the most novel way yet described of providing normal ventilatory requirements and, apart from extracorporeal membrane exchange, is probably the best technique available for testing the effects of lung 'rest' on disease progression.
In conclusion, recent work has brought to light a number of radically different methods which are capable of providing normal gas exchange in the presence of severe respiratory failure. Some of these have seriously challenged previous physiologic concepts such as 'deadspace' and it has been shown that it is possible to maintain normal gas exchange with respiratory rates that vary from zero to 30-40 cycles per second. These new methods of ventilatory support have also provided the opportunity to review critically the effects of current positive pressure ventilation techniques on the damaged lung. Recent results support the hypothesis that conventional ventilators may aggravate lung injury and indicate that it may be possible to avoid this by providing ventilatory support in ways that do not lead to large pressure-volume distortions of the airways. It seems likely that these alternative techniques for maintaining gas exchange will find a place in the future management of patients with severe respiratory failure, but the extent to which they will alter current practices remains uncertain.
